👀 Ones to watch: Undervalued stocks to buy before they report Q3 earningsSee Undervalued Stocks

Moderna Inc (MRNA)

Vienna
Currency in EUR
Disclaimer
54.13
0.00(0.00%)
Real-time Data
MRNA Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
53.5454.13
52 wk Range
51.57154.76
Bid/Ask
53.38 / 53.53
Prev. Close
54.13
Open
53.98
Day's Range
53.54-54.13
52 wk Range
51.57-154.76
Volume
0
Average Volume (3m)
300
1-Year Change
-42.88%
Fair Value
Unlock
Fair Value Upside
Unlock
MRNA Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
96.50
Upside
+65.55%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash
Show more

Moderna Inc Company Profile

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Compare MRNA to Peers and Sector

Metrics to compare
MRNA
Peers
Sector
Relationship
P/E Ratio
−3.8x−6.0x−0.6x
PEG Ratio
0.010.060.00
Price/Book
1.9x2.6x2.6x
Price / LTM Sales
4.4x12.1x3.2x
Upside (Analyst Target)
-68.9%46.9%
Fair Value Upside
Unlock6.9%7.9%Unlock

People Also Watch

80.51
PYPL
+1.94%
83.24
SHOP
+0.64%
123.61
XOM
+0.38%
106.92
MU
+1.16%
134.80
NVDA
-0.01%

FAQ

What Is the Moderna (MRNA) Stock Price Today?

The Moderna stock price today is 54.13

What Stock Exchange Does Moderna Trade On?

Moderna is listed and trades on the Vienna stock exchange.

What Is the Stock Symbol for Moderna?

The stock symbol for Moderna is "MRNA."

What Is the Moderna Market Cap?

As of today, Moderna market cap is 20.49B.

What is Moderna Earnings Per Share?

The Moderna EPS is -15.36.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.